7Baggers
 Published on: 2025-11-15 14:41:03  newser.com Sat, 15 Nov 2025 20:41:03 GMT
 published on: 2025-11-14 17:54:21  newser.com Fri, 14 Nov 2025 23:54:21 GMT
 published on: 2025-11-13 23:25:20  newser.com Fri, 14 Nov 2025 05:25:20 GMT
 minerva neurosciences secures $200m for drug trials  MSN Wed, 12 Nov 2025 01:43:13 GMT
 Minerva Neurosciences Reports Q3 2025 Financial Results  TipRanks Tue, 11 Nov 2025 04:09:56 GMT
 A Critical Year Ahead for Minerva Neurosciences  AD HOC NEWS Sat, 08 Nov 2025 13:05:04 GMT
 Minerva Neurosciences Tightens Belt, Prepares For Phase 3 Push  Finimize Thu, 06 Nov 2025 17:33:40 GMT
 minerva neurosciences (nerv): analyst cuts price target while ma  GuruFocus Thu, 06 Nov 2025 12:11:46 GMT
 minerva neurosciences: q3 earnings snapshot  CT Insider Thu, 06 Nov 2025 11:06:00 GMT
 published on: 2025-11-05 23:39:22  newser.com Thu, 06 Nov 2025 05:39:22 GMT
 minerva neurosciences tightens belt, prepares for phase 3 push  Finimize Wed, 05 Nov 2025 17:27:00 GMT
 Minerva Neurosciences (NERV) Advances Roluperidone with New Fina  GuruFocus Wed, 05 Nov 2025 13:11:24 GMT
 Minerva Neurosciences reports $2.7 mln Q3 net loss  TradingView Wed, 05 Nov 2025 12:39:23 GMT
 Minerva Neurosciences, Inc. SEC 10-Q Report  TradingView Wed, 05 Nov 2025 12:03:00 GMT
 published on: 2025-11-05 04:04:47  newser.com Wed, 05 Nov 2025 10:04:47 GMT
 Minerva Neurosciences: Q3 Earnings Snapshot  theheraldreview.com Wed, 05 Nov 2025 08:00:00 GMT
 published on: 2025-11-04 23:26:19  newser.com Wed, 05 Nov 2025 05:26:19 GMT

Minerva Neurosciences, Inc
(NASDAQ:NERV) 

NERV stock logo

Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone, a compound in Phase III clinical trial for the treatment o...

Founded: 2007
Full Time Employees: 13
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends